The company maintains a pristine capital structure with zero debt and a robust current ratio of 4.91 as of 2026Q3.
| Metric | TTM | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 |
|---|
| Total Current Assets | 50.23M | 45.08M | 44.17M | 37.79M | 34.54M | 31.7M | 28.02M | 24.54M | 22.21M | 18.48M | 15.82M | 12.59M | 10.62M | 12.42M | 16.3M | 16.63M | 9.44M | 8.41M | 6.55M |
| Cash & Short-Term Investments | 16.98M | 15.29M | 16.08M | 7.37M | 8.15M | 11.89M | 10.48M | 7.81M | 7.46M | 5.57M | 5.12M | 3.6M | 1.5M | 503.56K | 1.7M | 4.09M | 610.73K | 361.92K | 1.44M |
| Cash Only | 16.98M | 15.29M | 16.08M | 7.37M | 8.15M | 11.89M | 10.48M | 7.81M | 7.46M | 5.57M | 5.12M | 3.6M | 1.5M | 503.56K | 1.7M | 4.09M | 610.73K | 361.92K | 1.44M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 28.25M | 25.7M | 24.05M | 24.62M | 21.34M | 17.43M | 13.84M | 13.76M | 12.59M | 9.95M | 7.8M | 6.52M | 6.49M | 9.55M | 11.19M | 9.59M | 6.58M | 6.35M | 3.93M |
| Days Sales Outstanding | 136.7 | 146.55 | 160.45 | 186.93 | 186.96 | 177.88 | 155.62 | 160.41 | 162.31 | 140.43 | 123.89 | 122.59 | 152.88 | 230.83 | 209.22 | 184.25 | 167.83 | 178.26 | 163.88 |
| Inventory | 3.29M | 3.3M | 3.71M | 4.22M | 3.18M | 2.11M | 3.08M | 2.62M | 2.36M | 2.56M | 2.48M | 2.07M | 2.24M | 1.38M | 2.39M | 1.86M | 1.47M | 1.18M | 849.51K |
| Days Inventory Outstanding | 81.54 | 85.83 | 104.3 | 133.41 | 113.53 | 91.3 | 154.87 | 128.43 | 131.87 | 176.51 | 176.98 | 130.22 | 168.1 | 108.17 | 162.33 | 129.63 | 136.75 | 128.81 | 144.42 |
| Other Current Assets | 1.7M | 408K | 1 | 1.58M | 0 | 0 | 262K | 0 | 0 | 0 | 0 | 0 | 0 | 557K | 656K | 722K | 514K | 357K | 159K |
| Total Non-Current Assets | 9.25M | 8.72M | 8.06M | 8.02M | 6.83M | 5.41M | 5.22M | 4.82M | 4.43M | 4.58M | 4.77M | 4.82M | 5.17M | 5.13M | 4.62M | 4.23M | 4.7M | 3.05M | 2.85M |
| Property, Plant & Equipment | 5.21M | 4.91M | 5.25M | 5.67M | 4.69M | 3.69M | 3.87M | 3.6M | 3.09M | 3.3M | 3.38M | 3.64M | 3.94M | 3.74M | 3.17M | 2.81M | 2.69M | 2.73M | 2.28M |
| Fixed Asset Turnover | 13.89x | 13.03x | 10.42x | 8.47x | 8.89x | 9.68x | 8.39x | 8.68x | 9.16x | 7.83x | 6.81x | 5.34x | 3.94x | 4.03x | 6.16x | 6.77x | 5.32x | 4.76x | 3.85x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.23B | 0 | 0 | 0 |
| Intangible Assets | 354K | 1.32M | 657K | 605K | 599K | 663K | 598K | 581.41K | 649.1K | 721.28K | 904.03K | 999.84K | 930.45K | 1.08M | 1.17M | 1.24B | 1.06M | 228.78K | 183.66K |
| Long-Term Investments | 0 | 0 | 0 | 0 | -120M | -88K | 0 | -44 | 0 | 0 | 0 | 0 | 0 | -557M | -656M | -722M | -513.17M | 0 | 0 |
| Other Non-Current Assets | 1.22M | 2.48M | 2.15M | 161K | 120M | 88K | 755K | 44 | 91.91K | 99.87K | 144.26K | 182.7K | 302.6K | 309.82K | 274.94K | 191.96K | 128.79K | 88.02K | 30.96K |
| Total Assets | 59.47M | 53.8M | 52.23M | 45.81M | 41.36M | 37.11M | 33.24M | 29.35M | 26.64M | 23.06M | 20.59M | 17.41M | 15.79M | 17.56M | 20.92M | 20.87M | 14.14M | 11.46M | 9.4M |
| Asset Turnover | 1.29x | 1.19x | 1.05x | 1.05x | 1.01x | 0.96x | 0.98x | 1.07x | 1.06x | 1.12x | 1.12x | 1.12x | 0.98x | 0.86x | 0.93x | 0.91x | 1.01x | 1.13x | 0.93x |
| Asset Growth % | 31.04% | 3% | 14.03% | 10.74% | 11.47% | 11.62% | 13.25% | 10.2% | 15.51% | 12.01% | 18.28% | 10.21% | -10.05% | -16.09% | 0.25% | 47.55% | 23.4% | 21.98% | - |
| Total Current Liabilities | 10.23M | 10.47M | 7.68M | 8.05M | 7.15M | 4.64M | 2.99M | 3.62M | 4.74M | 2.9M | 3.07M | 2.28M | 1.82M | 2.19M | 4.17M | 4.41M | 4.5M | 2.1M | 2.63M |
| Accounts Payable | 2.6M | 2.67M | 1.01M | 1.37M | 1.26M | 685K | 556K | 586.58K | 810.64K | 663.38K | 589.23K | 538.52K | 380.58K | 643.68K | 749.99K | 733.62K | 1.24M | 426.32K | 339.28K |
| Days Payables Outstanding | 63.24 | 69.39 | 28.38 | 43.37 | 45.05 | 29.59 | 27.91 | 28.73 | 45.28 | 45.75 | 42.04 | 33.84 | 28.62 | 50.47 | 50.89 | 51.24 | 115.28 | 46.59 | 57.68 |
| Short-Term Debt | 0 | 0 | 0 | 80K | 0 | 33K | 0 | 0 | 1.1M | 50.7K | 46.31K | 48.75K | 46.38K | 57.54K | 2.02M | 2.21M | 2.17M | 392.25K | 370.98K |
| Deferred Revenue (Current) | 0 | 0 | 0 | -80K | 1.54M | 0 | 0 | -30.32K | 397.39K | 1.54M | 1.78M | 1.03M | 693.52K | 812.29K | 637K | 1.03M | 672.87K | 334.03K | 0 |
| Other Current Liabilities | 7.63M | 1.65M | 1.84M | 1.45M | -203K | 940K | 740K | 1.13M | 1.16M | 1.24M | 947.19K | 991.64K | 1M | 927.27K | 761.56K | 605.26K | 431.37K | 404.13K | 0 |
| Current Ratio | 4.91x | 4.31x | 5.75x | 4.69x | 4.83x | 6.83x | 9.38x | 6.78x | 4.68x | 6.38x | 5.15x | 5.52x | 5.84x | 5.66x | 3.91x | 3.77x | 2.10x | 4.01x | 2.49x |
| Quick Ratio | 4.59x | 3.99x | 5.27x | 4.17x | 4.39x | 6.38x | 8.35x | 6.05x | 4.19x | 5.50x | 4.34x | 4.61x | 4.61x | 5.03x | 3.34x | 3.35x | 1.77x | 3.45x | 2.17x |
| Cash Conversion Cycle | 155.01 | 162.99 | 236.37 | 276.98 | 255.44 | 239.59 | 282.57 | 260.11 | 248.9 | 271.19 | 258.83 | 218.97 | 292.37 | 288.53 | 320.66 | 262.64 | 189.3 | 260.47 | 250.62 |
| Total Non-Current Liabilities | 81K | 125K | 12K | 86K | 41K | 54K | 9K | 14.74K | 0 | 1.1M | 1.16M | 1.2M | 1.25M | 1.44M | 1.67M | 1.75M | 2.18M | 3.3M | 2.73M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.1M | 1.15M | 1.2M | 1.25M | 1.33M | 1.39M | 1.58B | 2.03M | 3.17M | 2.73M |
| Capital Lease Obligations | 125K | 125K | 12K | 81K | 41K | 54K | 9K | 14.74K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 80K | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 103K | 280K | 167K | 145K | 137K | 0 |
| Other Non-Current Liabilities | 81K | 0 | 0 | 5K | 0 | 0 | -1 | 0 | 0 | 0 | 9.74K | 0 | 0 | 0 | 0 | -1.58B | 0 | 0 | 0 |
| Total Liabilities | 10.31M | 10.59M | 7.69M | 8.14M | 7.19M | 4.69M | 2.99M | 3.62M | 4.74M | 3.99M | 4.23M | 3.48M | 3.07M | 3.63M | 5.84M | 6.16M | 6.68M | 5.4M | 5.35M |
| Total Debt | 0 | 198K | 87K | 161K | 41K | 87K | 81K | 45.06K | 1.1M | 1.15M | 1.2M | 1.25M | 1.3M | 1.39M | 3.41M | 3.79M | 4.2M | 3.56M | 3.1M |
| Net Debt | -16.98M | -15.09M | -15.99M | -7.21M | -8.11M | -11.8M | -10.4M | -7.76M | -6.35M | -4.43M | -3.92M | -2.35M | -205.13K | 886.43K | 1.71M | -303.24K | 3.59M | 3.2M | 1.66M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.05x | 0.06x | 0.07x | 0.09x | 0.10x | 0.10x | 0.23x | 0.26x | 0.56x | 0.59x | 0.77x |
| Debt / EBITDA | 0.00x | 0.02x | 0.01x | 0.03x | 0.01x | 0.02x | 0.01x | 0.01x | 0.31x | 0.27x | 0.31x | 0.61x | - | - | 3.00x | 1.63x | 1.96x | 1.28x | 5.14x |
| Net Debt / EBITDA | -1.17x | -1.37x | -2.15x | -1.56x | -2.25x | -3.15x | -1.77x | -2.07x | -1.81x | -1.02x | -1.02x | -1.15x | - | - | 1.50x | -0.13x | 1.67x | 1.15x | 2.75x |
| Interest Coverage | - | - | - | - | - | - | - | - | - | 53.34x | 46.54x | 15.24x | -8.10x | -13.68x | 3.42x | 9.83x | 6.66x | 8.83x | 0.72x |
| Total Equity | 49.17M | 43.21M | 44.55M | 37.67M | 34.17M | 32.42M | 30.25M | 25.73M | 21.9M | 19.07M | 16.36M | 13.92M | 12.72M | 13.93M | 15.08M | 14.71M | 7.46M | 6.06M | 4.04M |
| Equity Growth % | 20.96% | -3% | 18.26% | 10.22% | 5.42% | 7.16% | 17.55% | 17.53% | 14.83% | 16.56% | 17.49% | 9.46% | -8.66% | -7.65% | 2.54% | 97.07% | 23.17% | 49.93% | - |
| Book Value per Share | 5.69 | 4.96 | 5.03 | 4.33 | 3.90 | 3.64 | 3.43 | 2.98 | 2.54 | 2.25 | 1.98 | 1.71 | 1.57 | 1.72 | 1.86 | 1.88 | 1.22 | 1.01 | 0.63 |
| Total Shareholders' Equity | 49.17M | 43.21M | 44.55M | 37.67M | 34.17M | 32.42M | 30.25M | 25.73M | 21.9M | 19.07M | 16.36M | 13.92M | 12.72M | 13.93M | 15.08M | 14.71M | 7.46M | 6.05M | 4.04M |
| Common Stock | 83K | 83K | 87K | 86K | 85K | 85K | 86K | 84.08K | 82.89K | 82.3K | 81.87K | 81.34K | 81.14K | 81.14K | 81.14K | 81K | 61.88K | 60.47K | 58.81K |
| Retained Earnings | 25.14M | 21.18M | 23.67M | 18.79M | 15.78M | 14.92M | 13.68M | 9.52M | 6.86M | 4.96M | 2.73M | 514.67K | -577.81K | 710.78K | 2.04M | 1.85M | 797.87K | -118.47K | -1.45M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.74M | -3.24M | -3.02M | -2.63M | -2.35M | -1.97M | -1.6M | 0 | -1.03M | -737K | -757K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.6K | 4.66K |
Single product concentration risk
As reported in recent financial statements, Electromed has steadily grown its total assets from $47.0 million in 2024Q2 to $59.5 million in 2026Q3, a trend driven primarily by the consistent accumulation of retained earnings rather than external financing or debt-fueled expansion strategies.
The consistent upward trajectory in total assets suggests that the company is successfully converting its high-margin operational success into a more robust balance sheet. This accumulation of equity provides a significant buffer that enhances the company's ability to weather potential regulatory shifts in the reimbursement landscape.
According to quarterly balance sheet data, Electromed maintains a current ratio consistently above 4.8, with cash reserves reaching $17.0 million in 2026Q3, providing a substantial liquidity cushion against the inherent delays associated with the third-party payer reimbursement cycle and potential working capital fluctuations.
This high liquidity profile indicates that the company is well-positioned to fund its ongoing sales force expansion without the need for external capital. Investors should monitor whether this cash pile remains idle or if management identifies an accretive use of capital to diversify the current single-product revenue stream.
Based on the provided figures, equity has expanded from $40.3 million in 2024Q2 to $49.2 million in 2026Q3, a growth trajectory fueled entirely by retained earnings and the absence of dilutive equity issuances or significant stock-based compensation programs common in the medical device sector.
The reliance on internally generated capital to drive equity growth signals a disciplined approach to shareholder value. This structure avoids the earnings dilution that often pressures the valuations of smaller medical technology firms, thereby preserving the integrity of the company's per-share value.
While the balance sheet appears pristine, the company's reliance on third-party payer reimbursement, as noted in financial disclosures, suggests that the quality of assets is heavily dependent on the efficiency of the billing department and the stability of Medicare and private insurance coverage policies.
The headline strength of the balance sheet may mask the underlying sensitivity to administrative friction, where any deterioration in the reimbursement cycle could lead to a rapid increase in accounts receivable. Investors should remain cautious, as the company's financial health is intrinsically linked to its ability to navigate complex medical necessity documentation.
Quick answers to the most common questions about buying ELMD stock.
As of 2025, Electromed, Inc. (ELMD) had total assets of $53.8M including $45.1M in current assets.
Electromed, Inc. (ELMD) carries total debt of $0.2M, offset by $15.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Electromed, Inc. (ELMD) has total shareholders' equity (book value) of $43.2M ($4.96 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Electromed, Inc. (ELMD) reported a current ratio of 4.31x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.